Trial Profile
A cohort study of herpes zoster (HZ) vaccine (Zostavax) assessing efficacy for at least 5 years in persons aged ≥60 years.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Therapeutic Use
- 18 Dec 2015 New trial record
- 11 Oct 2015 Results of preliminary analysis presented at the IDWeek 2015